Scientists ID gene activity changes linked to ALS neurodegeneration
Researchers have identified gene activity changes that might explain why motor nerve cells selectively degenerate in amyotrophic lateral sclerosis…
Articles by Lindsey Shapiro, PhD
Molecular analyses offer insights into novel ALS therapy approaches
New research into the molecular underpinnings of amyotrophic lateral sclerosis (ALS) has uncovered sex differences and disease subtypes, which could…
Study from Norway links physical activity to lower ALS risk in men
Men who are more active and physically fit have lower long-term risk of developing amyotrophic lateral sclerosis (ALS), according…
PrimeC continues to slow ALS progression: One-year trial data
Amyotrophic lateral sclerosis (ALS) patients who used NeuroSense Therapeutics‘ investigational therapy PrimeC for a year saw significantly…
ROCK inhibitor Bravyl shows early signs of efficacy for ALS
Bravyl, an investigational oral therapy from Woolsey Pharmaceuticals, was safe and lowered levels of the nerve damage biomarker neurofilament…
Radicava found to prolong survival in real-world analysis
Adding Radicava (edaravone) to riluzole prolongs survival of amyotrophic lateral sclerosis (ALS) patients by more than three months…
MIF protein slows disease progression in ALS mice, study finds
Increasing levels of the MIF protein may be a promising therapeutic strategy for slowing disease progression in amyotrophic lateral…
New US public-private partnership aims to accelerate ALS research
The Foundation for the National Institutes of Health (FNIH) is launching a public-private partnership to generate the largest openly available…
U of Cincinnati gifted $13.5M for ALS research, patient care work
The ALS Multidisciplinary Clinic at the University of Cincinnati Gardner Neuroscience Institute in Ohio has been gifted $13.5 million to…
Biomarker of oxidative stress could help track ALS progression: Study
A blood biomarker of oxidative stress, a type of cellular stress implicated in amyotrophic lateral sclerosis (ALS), is significantly…